Ferrer, R. A., Wobus, M., List, C., Wehner, R., Schönefeldt, C., Brocard, B., . . . Platzbecker, U. (2013). Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide. Ferrata Storti Foundation.
Chicago Style aipamenaFerrer, Ruben A., et al. Mesenchymal Stromal Cells From Patients With Myelodyplastic Syndrome Display Distinct Functional Alterations That Are Modulated By Lenalidomide. Ferrata Storti Foundation, 2013.
MLA aipamenaFerrer, Ruben A., et al. Mesenchymal Stromal Cells From Patients With Myelodyplastic Syndrome Display Distinct Functional Alterations That Are Modulated By Lenalidomide. Ferrata Storti Foundation, 2013.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.